Tower Research Capital LLC (Trc) Immunic, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Immunic, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,660 shares of IMUX stock, worth $9,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,660

Previous 3,925 120.64%

Holding current value

$9,699

Previous $6,000 33.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$1.0 - $1.61 $4,735 - $7,623	4,735 Added 120.64%	8,660 $8,000
Q3 2024 Nov 14, 2024	SELL	$1.08 - $1.95 $14,092 - $25,445	-13,049 Reduced 76.88%	3,925 $6,000
Q2 2024 Aug 13, 2024	SELL	$0.98 - $1.44 $25,095 - $36,875	-25,608 Reduced 60.14%	16,974 $18,000
Q1 2024 May 15, 2024	BUY	$1.14 - $1.53 $43,172 - $57,942	37,871 Added 803.88%	42,582 $56,000
Q4 2023 Feb 13, 2024	BUY	$0.97 - $1.6 $4,162 - $6,865	4,291 Added 1021.67%	4,711 $7,000
Q3 2023 Nov 14, 2023	SELL	$1.35 - $2.87 $9,979 - $21,215	-7,392 Reduced 94.62%	420 $0
Q2 2023 Aug 14, 2023	SELL	$1.33 - $2.51 $6,841 - $12,911	-5,144 Reduced 39.7%	7,812 $19,000
Q1 2023 May 09, 2023	SELL	$1.35 - $2.87 $21,602 - $45,925	-16,002 Reduced 55.26%	12,956 $19,000
Q4 2022 Feb 10, 2023	BUY	$1.13 - $10.8 $16,128 - $154,148	14,273 Added 97.19%	28,958 $40,000
Q3 2022 Nov 10, 2022	BUY	$3.0 - $5.49 $18,417 - $33,703	6,139 Added 71.83%	14,685 $46,000
Q2 2022 Aug 15, 2022	BUY	$3.13 - $12.25 $23,568 - $92,242	7,530 Added 741.14%	8,546 $29,000
Q1 2022 May 12, 2022	BUY	$9.54 - $14.26 $3,291 - $4,919	345 Added 51.42%	1,016 $11,000
Q4 2021 Feb 14, 2022	SELL	$7.34 - $10.25 $7,927 - $11,070	-1,080 Reduced 61.68%	671 $6,000
Q3 2021 Nov 15, 2021	SELL	$8.05 - $13.29 $119,252 - $196,878	-14,814 Reduced 89.43%	1,751 $15,000
Q2 2021 Aug 16, 2021	BUY	$11.76 - $16.85 $177,505 - $254,333	15,094 Added 1026.1%	16,565 $203,000
Q1 2021 May 17, 2021	SELL	$14.21 - $25.3 $88,485 - $157,543	-6,227 Reduced 80.89%	1,471 $24,000
Q4 2020 Feb 16, 2021	BUY	$14.8 - $20.37 $62,811 - $86,450	4,244 Added 122.87%	7,698 $118,000
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $27,154 - $50,886	2,313 Added 202.72%	3,454 $64,000
Q2 2020 Aug 13, 2020	SELL	$5.67 - $15.86 $5,437 - $15,209	-959 Reduced 45.67%	1,141 $14,000
Q1 2020 May 15, 2020	BUY	$4.22 - $9.8 $3,376 - $7,840	800 Added 61.54%	2,100 $13,000
Q4 2019 Feb 07, 2020	BUY	$6.4 - $10.23 $4,416 - $7,058	690 Added 113.11%	1,300 $13,000
Q3 2019 Nov 05, 2019	SELL	$10.0 - $17.01 $23,000 - $39,123	-2,300 Reduced 79.04%	610 $6,000
Q2 2019 Aug 13, 2019	BUY	$7.88 - $33.2 $22,930 - $96,612	2,910 New	2,910 $33,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

51.2M

Call Options Held

824K

Put Options Held

354K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $34.2M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Immunic, Inc. Transaction History